[Paclitaxel for treatment of advanced breast cancers].
作者信息
Ito Y
机构信息
Department of Medical Oncology, Cancer Institute Hospital.
出版信息
Nihon Rinsho. 2000 Apr;58 Suppl:259-64.
PMID:11026004
Abstract
摘要
相似文献
1
[Paclitaxel for treatment of advanced breast cancers].
Nihon Rinsho. 2000 Apr;58 Suppl:259-64.
2
[Docetaxel hydrate for treatment of advanced breast cancers].
Nihon Rinsho. 2000 Apr;58 Suppl:254-8.
3
HER2 and response to paclitaxel in node-positive breast cancer.
N Engl J Med. 2008 Jan 10;358(2):197; author reply 198.
4
HER2 and response to paclitaxel in node-positive breast cancer.
N Engl J Med. 2008 Jan 10;358(2):197; author reply 198. doi: 10.1056/NEJMc073152.
5
HER2 and response to paclitaxel in node-positive breast cancer.
N Engl J Med. 2008 Jan 10;358(2):198; author reply 198-9.
6
Cardiac dysfunction in cancer patients receiving paclitaxel.
Eur J Nucl Med. 1998 Apr;25(4):446-7.
7
[Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice].
Bull Cancer. 2002 Mar;89(3):275-82.
8
Genentech's anticancer Mab expected by November.
Nat Biotechnol. 1998 Jul;16(7):615. doi: 10.1038/nbt0798-615.
9
Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Semin Oncol. 1996 Oct;23(5 Suppl 11):46-56.
10
Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
Semin Oncol. 1996 Feb;23(1 Suppl 1):10-2.
Zotero 插件